Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.31
09.12.25
€8.59
09.12.26
-6.87%
08:05

HC Wainwright 
09.12.25 50%
buy
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.31
08.12.25
-
08.12.26
-6.87%
08:05

UBS Group AG 
08.12.25 50%
buy
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.31
08.12.25
-
08.12.26
-6.87%
08:05

HC Wainwright 
08.12.25 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.92
30.11.25
-
30.11.26
32.61%
08:05

StockNews.com 
30.11.25 50%
buy
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.66
27.09.25
-
27.09.26
84.85%
08:05

melinda 
27.09.25 10%
buy
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.00
01.04.25
€11.55
01.04.26
-1.50%
02.04.26

WBB Securities 
01.04.25 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.78
26.10.24
€2.00
26.10.25
-1.59%
09.11.24

Higher EBIT margin than peer group
Revenue growth >5% per year expected
Fair valuation
positive Cash Flow expected
nvestor 
26.10.24 50%
buy
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.26
21.10.24
€17.56
21.10.25
-77.15%
22.10.25

LADENBURG THALM/SH SH 
21.10.24 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.28
09.06.24
€1.00
09.06.25
18.29%
22.06.24

Higher EBIT margin than peer group
Revenue growth >5% per year expected
Fair valuation
positive Cash Flow expected
nvestor 
09.06.24 50%
buy
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.08
30.04.24
€10.26
30.04.25
-77.82%
01.05.25

LADENBURG THALM/SH SH 
30.04.24 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€25.00
20.03.21
€10.00
20.03.22
-28.40%
03.04.21

Higher EBIT margin than peer group
Revenue growth >5% per year expected
Fair valuation
positive Cash Flow expected
nvestor 
20.03.21 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€11.70
03.11.20
-
04.11.21
59.83%
15.07.21

Biotechhunter 
03.11.20 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€11.90
30.10.20
-
03.11.20
-1.68%
03.11.20

Biotechhunter 
30.10.20 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.30
01.10.20
-
30.10.20
-3.25%
30.10.20

Biotechhunter 
01.10.20 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€13.40
29.09.20
-
01.10.20
-8.21%
01.10.20

Biotechhunter 
29.09.20 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€13.40
25.09.20
-
29.09.20
0.00%
29.09.20

Biotechhunter 
25.09.20 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€13.30
15.09.20
-
25.09.20
0.75%
25.09.20

Biotechhunter 
15.09.20 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.80
07.09.20
-
15.09.20
3.91%
15.09.20

Biotechhunter 
07.09.20 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€13.70
27.08.20
-
07.09.20
-6.57%
07.09.20

Biotechhunter 
27.08.20 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.60
25.08.20
-
27.08.20
-6.16%
27.08.20

Biotechhunter 
25.08.20 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€15.10
17.08.20
-
25.08.20
-3.31%
25.08.20

Biotechhunter 
17.08.20 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€16.20
13.08.20
-
17.08.20
-6.79%
17.08.20

Biotechhunter 
13.08.20 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€16.90
31.07.20
-
13.08.20
-4.14%
13.08.20

Biotechhunter 
31.07.20 50%
buy
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€18.50
01.07.20
-
31.07.20
-8.65%
31.07.20

Biotechhunter 
01.07.20 50%
sell
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.40
26.06.20
-
01.07.20
6.32%
01.07.20

Biotechhunter 
26.06.20 50%